Literature DB >> 859285

[About degradation products of the inter-alpha-trypsin inhibitor in serum. II. Acid label derivatives of the inter-alpha-trypsin inhibitor (author's transl)].

K Hochstrasser, J Niebel, K Lempart.   

Abstract

Simultaneous to the liberation of the acid stable trypsin-plasmin-inhibitor from the inter-alpha-trypsininhibitor in vivo, acid labile degradation products are set free. The main product can be estimated by immunological methods. This product is not excreted by the kidney in contrast to the acid stable inhibitor. The product accumulates in serum in different diseases. An increased concentration of this product indicates also an increased turn-over of the inter-alpha-trypsin inhibitor in the case when the concentraton of the intact inter-alpha-trypsin inhibitor or of the filtrable derivative are within normal range.

Mesh:

Substances:

Year:  1977        PMID: 859285     DOI: 10.1007/BF01488113

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  2 in total

1.  Liberation of an acid stable proteinase inhibitor from the human inter-alpha-trypsin inhibitor by the action of kallikrein.

Authors:  G Bretzel; K Hochstrasser
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-03

2.  [Humoral inter-alpha-trypsin inhibitor as an inhibitogen for secretory proteinase inhibitors. Serum concentration in adults and in children with respiratory tract diseases].

Authors:  K Hochstrasser; B Rasche; C Mietens; K Schorn; C E Pilar; A Bum
Journal:  Pneumonologie       Date:  1976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.